Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA. A randomized, double-blind, crossover study.

Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA. A randomized, double-blind, crossover study. - Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037558

Enrollment

Registered

2019-08-01

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of test food for 2 weeks Ingestion of control food for 2 weeks

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Age: 20 -65 years old 2. Sex : Male 3. BMI:18.5-30 kg/m2 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patient with dyslipidaemia 2. Medical treatment for some diseases 3. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases 4. Sublects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 5. Can't stop to take a supplement during the study period. 6. Difficulty in collecting blood. 7. Smoker 8. Subjects who are planned to participate in other clinical study. 9. Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

Measure	Time frame
Serum DHA concentration Before 1 week, 0 week, 1week, 2weeks	—

Secondary

Measure	Time frame
Serum EPA concentration Before 1 week, 0 week, 1week, 2weeks	—

Countries

Japan

Contacts

Public ContactReiko Naito

Kenkoin Medical Corporation Foundation Kenkoin Clinic

reiko-naito@kenkoin.jp03-3573-1153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026